• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Monday, June 8, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

US drug firms face jury over opioid addiction epidemic

Published on: June 30, 2021 12:14 PM

US pharmaceutical firms accused of stoking a two-decade epidemic of opioid addiction that has seen 500,000 die from overdoses stood trial before a jury for the first time Tuesday.

The suit launched by two counties in New York state charges the leading drugmakers and distributors with earning huge profits by pushing highly addictive prescription opioids like Oxycontin that cost local authorities billions of dollars for social services in dealing with the fallout from the epidemic. “This case is about one thing: corporate greed,” the suit says. The drug makers and distributors “put their desire for profits above the health and wellbeing” of the citizens of the counties, the suit said. On trial are firms including Actavis, Cardinal Health and Amerisource, dominant powers in the US healthcare industry. The initial complaint also included Purdue Pharma, whose involvement in the case has been paused due to bankruptcy, and Johnson & Johnson, which is no longer part of the lawsuit after announcing a settlement over the weekend, among others. Civil and criminal charges have been launched in front of judges around the country against the firms, with some of those cases resulting in negotiated settlements for heavy damages.

The case that opened in Central Islip, New York Tuesday will be the first in which the companies will be judged by a jury of citizens, who could, if convinced of their guilt, award the counties massive damages that could create a framework for similar suits and jury trials all around the country. “The evidence is going to show that the manufacturing defendants misled doctors and patients by claiming that the risk of addiction was rare,” said Jayne Conroy, who represents the Long Island county of Suffolk, one of the two counties named as plaintiffs in the suit. “The opioid epidemic didn’t happen by accident. It happened because of a calculated decision in boardrooms across the country to decide to try to make a blockbuster drug… that everyone knew was addictive, and cause death,” said Hunter Shkolnik, representing Nassau County. On the eve of the trial four major pharmacy chains including CVS and Walgreens were dropped from the list of defendants because they had reached settlements with the state, according to news reports. The trial is taking place in a university auditorium because the courtroom is not large enough to contain all of the defendants and their attorneys. It is expected to last six to eight weeks.

Filed Under: World Tagged With: Addiction, Drugs, Justice, Latest, trial, US

Submit a Comment




Primary Sidebar




Latest News

PFF president hails national men’s team for ending 64-year wait

Maryam Nawaz unveils major Lahore urban renewal project

UoR earns NTC thumbs-up, sets new benchmarks in technology education

US weighs Iranian assets plan as Gulf tensions rise

Punjab shifts to digital land ownership system from July

Pakistan

Maryam Nawaz unveils major Lahore urban renewal project

UoR earns NTC thumbs-up, sets new benchmarks in technology education

Punjab shifts to digital land ownership system from July

Bilawal calls urgent PPP meeting over AJK tensions

Punjab launches QR panic button system for transport safety upgrade

More Posts from this Category

Business

Pakistan savings rate hits 30-year low raising economic concerns

PSX new IPOs deliver 47% average return, boosting investor confidence

Pakistan signs MoU with Saudi, local firms to develop Karachi maritime business district

Gold prices witness sharp decline

Gul Ahmed venture QGDC announces $230m investment to set up Pakistan’s largest data centre

More Posts from this Category

World

US weighs Iranian assets plan as Gulf tensions rise

King Charles signals unity as royals gather at wedding

Pakistan tells un Kashmir dispute remains unresolved integral issue

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.